12.04.2012
- Watson Pharmaceuticals is on track to announce a deal to buy Actavis for around $6 billion by the end of April, creating one of the world's biggest producers of generic drugs...
22.03.2012
- Watson Pharmaceuticals Inc is close to buying Swiss-based Actavis for around $7 billion, marking the latest deal between generics companies racing to achieve economies of scale...
18.03.2010
- Israel's Teva has won the battle for German generic drugmaker Ratiopharm, three sources said, fixing the industry leader's weakness in the world's second-largest generics market...
18.03.2010
- The tussle over German generic drugs maker Ratiopharm is drawing to a close as the three remaining contenders square off in the final round of bidding, sources close to the deal...
17.03.2010
- Pfizer will on Wednesday place an offer in the final round of bids for German generic drug maker Ratiopharm, a person briefed on the matter told Reuters on Wednesday. Ratiopharm's...
11.03.2010
- Ratiopharm owner Ludwig Merckle has turned down offers for drugs distributor Phoenix, as he struggles to retain control over his late father's diminished business empire, sources...
09.03.2010
- Actavis, the indebted Icelandic generic drugs maker looking to buy German peer Ratiopharm, has raised the prospect of taking the enlarged company public should it win the auction...
08.03.2010
- Pfizer wheeled out its chief executive and pledged to invest in growth as it sought to win the bidding to buy German generic drugmaker Ratiopharm, sources familiar with the...
